Syngene stock falls 1.71 percent as Q1 loss weighs

Published on 10/04/2026 at 15:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Syngene stock fell 1.71 percent to INR 359.05 on October 1, 2026, after weak Q1 FY27 figures. Revenue fell 16 percent to INR 7.36 billion.

Syngene, INE398A01010, Illustration mit AI erstellt.

Syngene International stock (ISIN INE398A01010) closed at INR 359.05 on the NSE on October 1, 2026, down 1.71 percent from INR 365.30. The decline followed a difficult first quarter in which revenue fell 16 percent year over year to INR 7.36 billion and the company reported a consolidated net loss of INR 90 million.

Q1 loss resets the earnings story

According to Sahi Markets, Syngene's Q1 FY27 revenue from operations fell to INR 736 crore for the quarter ended June 30, 2026. Operating EBITDA was INR 91 crore, with the margin at 12 percent compared with 24 percent in Q1 FY26, while the loss followed a profit of INR 87 crore a year earlier.

The operating figures point to a broader reset rather than a one-line earnings miss. Management guided to a single-digit revenue decline in rupee terms for FY27, while expecting EBITDA margins in the mid-20s and profitable double-digit growth in FY28, according to Sahi Markets.

Client demand remains the swing factor

Financial Express reported on October 2, 2026, that a major large-molecule client reduced offtake during Q1 FY27 and that foreign-exchange hedge losses also affected the quarter. The report said Syngene expects business momentum to improve in the second half of FY27.

The same report identified antibody-drug conjugates as a longer-term opportunity because those products were included in a US tariff exemption update. Syngene's Bengaluru facility is still under construction, so the opportunity is tied to future capacity and customer programs rather than the FY27 earnings base.

Target remains above the share price

Yahoo Finance lists Syngene's average analyst target at INR 501.88, compared with the October 1 price of INR 359.05. The target lies 39.8 percent above the price, while the published target range runs from INR 340.00 to INR 735.00.

Stock sits near its yearly low

Syngene stock closed at INR 359.05 on October 1, 2026, on the NSE. Its 52-week range was INR 353.30 to INR 678.95, placing the close 1.6 percent above the yearly low and 47.1 percent below the high.